iSpecimen Inc. (ISPC), a biospecimen procurement company, announced plans to build a $200 million digital asset trove, aiming to diversify its balance sheet and support growth initiatives through tokenized real-world assets and leading cryptocurrencies. iSpecimen is continuing parallel discussions to develop a financial plan based on the Solana blockchain. The company plans to purchase Solana tokens (SOL) through over-the-counter transactions with institutional cryptocurrency institutions, including locked Solana tokens with contractual transfer or vesting restrictions. (Investing)